why should chromosome 1 abnormalities be assessed in all patients with mm?
Published 2 years ago • 413 plays • Length 1:51Download video MP4
Download video MP3
Similar videos
-
2:52
the relationship between chromosome 1 abnormalities and poor prognosis in multiple myeloma
-
9:25
the 'messy' data on chromosome 1 abnormalities and multiple myeloma treatment - medpage today
-
2:43
multiomic mapping of aberrations on chromosome 1 in myeloma
-
4:07
why is it important for #myeloma patients to know the cytogenetic abnormalities of their cancer?
-
1:52
subclonal evolution and cytogenetic aberrations in myeloma
-
2:38
myeloma targeted therapy: why identifying chromosomal abnormalities is key
-
11:05
do all my #myeloma cells have the same chromosomal mutations? what is clonal heterogeneity?
-
56:16
exploring the molecular basis of vhl disease – genetics of vhl | medical symposium 2024
-
12:50
how does genetic testing help assess risk? why is knowing risk stratification important?
-
1:21
when should myeloma genetic testing be done? #myeloma
-
1:18
dr. kumar discusses genetic abnormalities in myeloma
-
11:47
do all my #myeloma cells same chromosomal mutations? what is clonal heterogeneity? (part 2)
-
3:31
is monosomy 13 a high-risk marker for myeloma?
-
9:13
what are the different types of chromosomal mutations? (e.g. translocations) #myeloma
-
34:39
peter voorhees, md: understanding your multiple myeloma genetics: mcrt charlotte 2018
-
18:52
genetic effects on gene expression and survival in patients with multiple myeloma | heini natri
-
1:02:21
gprc5d and fcrh5 targeted therapies in myeloma
-
4:21
how to better diagnose patients with high-risk myeloma | martin kaiser, md | ash 2022